Table 3.
Comparison of model for end-stage liver disease score, modified medical research council dyspnea score, and respiratory muscle strength indices between ascites and non-ascites liver disease patients
| All patients (n = 40) | Ascites (n = 17) | Non-ascites (n = 23) | P value | |
| MELD | 14 ± 6 | 17 ± 7 | 12 ± 5 | 0.0061 |
| mMRC | 2.0 ± 1.2 | 2.2 ± 1.1 | 1.9 ± 1.2 | 0.4441 |
| Pemax, %pred | 105 ± 35 | 87 ± 30 | 118 ± 33 | 0.004 |
| Pimax, %pred | 90 ± 29 | 72 ± 20 | 103 ± 28 | < 0.001 |
| RMS, %pred | 97 ± 30 | 79 ± 23 | 110 ± 28 | < 0.001 |
Values are mean ± SD obtained in a sitting position. Statistical significance tested with Student’s t test between ascites and non-ascites groups.
1
For MELD and mMRC Mann-Whitney rank sum test was used. MELD: Model for end-stage liver disease; mMRC: Modified medical research council; Pemax: Maximum static expiratory mouth pressure; %pred: Percent of predicted; Pimax: Maximum static inspiratory mouth pressure; RMS: Respiratory muscle strength.